Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
John Wiley & Sons B | WLYB | Nov 1, 2024 | 49.78 | +1.47 |
Johnson & Johnson | JNJ | Nov 1, 2024 | 160.13 | +0.17 |
Johnson Controls International | JCI | Nov 1, 2024 | 75.50 | -0.07 |
Johnson Outdoors A | JOUT | Nov 1, 2024 | 32.08 | +1.45 |
Joint Stock Company Kaspi.kz | KSPI | Nov 1, 2024 | 108.83 | -1.19 |
Jones Lang LaSalle | JLL | Nov 1, 2024 | 265.00 | -2.20 |
Journey Medical | DERM | Nov 1, 2024 | 6.17 | +7.30 |
Jowell Global | JWEL | Nov 1, 2024 | 1.74 | -2.25 |
JOYY ADR | YY | Nov 1, 2024 | 33.10 | -2.79 |
JP Morgan Chase | JPM | Nov 1, 2024 | 222.94 | +0.46 |
JP Morgan Chase & Co EE Pref | JPM-C | Nov 1, 2024 | 25.23 | -1.87 |
JP Morgan Chase & Co GG Pref | JPM-J | Nov 1, 2024 | 22.42 | -2.27 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Nov 1, 2024 | 24.89 | -2.20 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Nov 1, 2024 | 54.44 | -0.26 |
Jumia Technologies ADR | JMIA | Nov 1, 2024 | 4.57 | -0.65 |
Junee Limited - Ordinary Shares | JUNE | Nov 1, 2024 | 4.80 | -1.03 |
Junior Gold Miners ETF Market Vectors | GDXJ | Nov 1, 2024 | 50.84 | -1.43 |
Juniper Networks | JNPR | Nov 1, 2024 | 39.00 | +0.26 |
JVSPAC Acquisition | JVSA | Nov 1, 2024 | 10.37 | 0.00 |
JVSPAC Acquisition | JVSAU | Nov 1, 2024 | 10.75 | 0.00 |
JX Luxventure | JXJT | Nov 1, 2024 | 1.38 | +3.76 |
Kadant | KAI | Nov 1, 2024 | 343.38 | +3.10 |
Kairos Pharma | KAPA | Nov 1, 2024 | 1.34 | 0.00 |
Kairous Acquisition | KACL | Nov 1, 2024 | 12.30 | +1.82 |
Kaiser Aluminium | KALU | Nov 1, 2024 | 75.60 | +1.80 |
Kaival Brands Innovations Group | KAVL | Nov 1, 2024 | 1.02 | +2.00 |
Kaixin Auto | KXIN | Nov 1, 2024 | 4.32 | +5.88 |
Kala Bio | KALA | Nov 1, 2024 | 6.99 | -0.71 |
Kaltura | KLTR | Nov 1, 2024 | 1.32 | +3.94 |
KalVista Pharmaceuticals | KALV | Nov 1, 2024 | 10.61 | +3.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.